Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
ds-5141b (1 trial)
Muscular Dystrophies (Phase 2)
Muscular Dystrophy, Duchenne (Phase 2)
Trials (1 total)
Trial APIs (1 total)